Frommeyer Timothy C, Wu Tongfan, Gilbert Michael M, Brittain Garrett V, Fuqua Stephen P
Department of Pharmacology & Toxicology, Boonshoft School of Medicine, Wright State University, Dayton, OH 45435, USA.
Department of Neurology, Boonshoft School of Medicine, Wright State University, Dayton, OH 45435, USA.
Life (Basel). 2023 Feb 7;13(2):464. doi: 10.3390/life13020464.
Rising concerns of cerebral venous sinus thrombosis (CVST) and other forms of venous thromboembolism have been associated with the SARS-CoV-2 vaccinations. Adverse effects with vector-based vaccines are well documented in the literature, while less is known about the mRNA vaccines. This report documents a case of CVST in a 32-year-old female patient who received her second Pfizer mRNA COVID-19 vaccination 16 days prior to hospital admission and had started oral combined contraceptives approximately 4 months beforehand. Clinicians should be cognizant of the possibility that mRNA vaccines, when combined with other risk factors like oral contraceptive pill use, may enhance one's hypercoagulable status.
对新冠病毒疫苗接种后发生脑静脉窦血栓形成(CVST)及其他形式静脉血栓栓塞的担忧日益增加。基于载体的疫苗的不良反应在文献中有充分记载,而关于信使核糖核酸(mRNA)疫苗的了解则较少。本报告记录了一例32岁女性患者发生CVST的病例,该患者在入院前16天接种了第二剂辉瑞mRNA新冠疫苗,并且大约在4个月前开始口服复方避孕药。临床医生应认识到,mRNA疫苗与口服避孕药等其他风险因素合用时,可能会增强个体的高凝状态。